Slide 1: Second Quarter / First Half Year Results 2022
Second Quarter / First Half Year Results 2022 Analyst Presentation 28.07.2022
Slide 2: Disclaimer
2 Second Quarter / First Half Year Results 2022 28.07.2022 Disclaimer This presentation contains certain statements that are neither fluctuations, inflation, and consumer confidence, on a global, reported financial results nor other historical information. regional, or national basis. This presentat
Slide 3: Second Quarter 2022
CLARIANT™ Second Quarter 2022 what is precious to you?
Slide 4: Significant Sales Growth in Q2 2022
4 Second Quarter / First Half Year Results 2022 28.07.2022 Significant Sales Growth in Q2 2022… …20 % Price Contribution to Specialty Portfolio Growth 1 Q2 sales (continuing operations) up + 29 % (+ 25 % organic) in LC1 – + 9 % volume increase (+ 5 % organic, + 4 % M&A2) – + 20 % price contribution
Slide 5: Strong Growth in Q2 2022 Delivered Profitability Improvement
5 Second Quarter / First Half Year Results 2022 28.07.2022 Strong Growth in Q2 2022… …Delivered Profitability Improvement 2 Q2 EBITDA margin increased to 16.6 % – Q2 EBITDA improved by 80 basis points, driven by pricing measures, higher volumes, and cost savings EBITDA in CHF m – + 20 % pricing full
Slide 6: Executed Strategic Priorities in Q2 2022
6 Second Quarter / First Half Year Results 2022 28.07.2022 Executed Strategic Priorities in Q2 2022 3 Simplified Organizational & Leadership Structure New Executive Leadership Team1 – Clariant is reorganizing into three global Business Units (BUs) rather than five, with newly appointed presidents –
Slide 7: Natural Gas – Global Footprint of Specialty Chemicals Exposure
7 Second Quarter / First Half Year Results 2022 28.07.2022 Natural Gas – Global Footprint of Specialty Chemicals Exposure 4 First Half Year 2022 Regional Production vs. Regional Consumption 6.9 Regional Production1 Split Energy Cost as % of… 4.9 in tons Asia-Pacific Europe, Middle East & Africa 30 %
Slide 8: Second Quarter 2022 – Group Overview
8 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Group1,2 Overview in CHF m Q2 2022 Q2 2021 % CHF % LC3 H1 2022 H1 2021 % CHF % LC3 Business Area composition1 (in %) Sales 1 301 1 032 + 26 + 29 2 563 2 034 + 26 + 29 EBITDA 216 163 + 33 436 336 + 30 Sales EBITDA EBITDA
Slide 9: Second Quarter 2022 – Care Chemicals
9 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Care Chemicals1 in CHF m Q2 2022 Q2 2021 % CHF % LC2 H1 2022 H1 2021 % CHF % LC2 Market Dynamics Sales 551 384 + 43 + 46 1 117 788 + 42 + 45 – Global industrial demand and consumer EBITDA 133 76 + 75 263 156 + 69 market
Slide 10: Second Quarter 2022 – Catalysis
10 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Catalysis1 in CHF m Q2 2022 Q2 2021 % CHF % LC2 H1 2022 H1 2021 % CHF % LC2 Market Dynamics Sales 232 221 +5 +8 417 414 +1 +4 – Continued demand for more sustainable EBITDA 13 42 - 69 27 80 - 66 solutions and continued
Slide 11: Second Quarter 2022 – Natural Resources
11 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Natural Resources1 in CHF m Q2 2022 Q2 2021 % CHF % LC2 H1 2022 H1 2021 % CHF % LC2 Market Dynamics Sales 518 427 + 21 + 24 1 029 832 + 24 + 27 – Ongoing strong demand in global industrial EBITDA 88 69 + 28 190 138 + 3
Slide 12: First Half Year 2022 – Key Financials
12 Second Quarter / First Half Year Results 2022 28.07.2022 First Half Year 2022 – Key Financials in CHF m H1 2022 H1 20211 − First Half Year 2022 net result from continuing (restated) operations increased to CHF 189 m due to the strong Continuing operations business performance and corresponding ma
Slide 13: Performance Programs on Track to Meet 2025 Cost Savings Target of CHF 110 m
13 Second Quarter / First Half Year Results 2022 28.07.2022 Performance Programs on Track to Meet… …2025 Cost Savings Target of CHF 110 m 6 Focus on savings and disproportionate cash-out – Performance programs (mainly the efficiency programs) generated savings of ~ CHF 60 m in 2020 and 2021 ➔ 55 % o
Slide 14: Outlook Q3 2022
14 Second Quarter / First Half Year Results 2022 28.07.2022 Outlook Q3 2022 Care Chemicals Catalysis Natural Resources Group Q3 2022 Outlook: Q3 2022 Outlook: Q3 2022 Outlook: Q3 2022 Outlook: − Strong y-o-y sales growth in − Strong y-o-y and sequential − Strong y-o-y sales growth in − Strong LC1 sa
Slide 15: Outlook FY 2022
CLARIANT™ Outlook FY 2022 what is precious to you?
Slide 16: Full Year Outlook 2022 Confirmed and Substantiated
16 Second Quarter / First Half Year Results 2022 28.07.2022 Full Year Outlook 2022 Confirmed and Substantiated – Expect Strong Sales Growth and EBITDA Margin Improvement External Factors Internal Factors FY 2022 Group − Continued pricing measures to − Geopolitical conflict impacting global • Strong
Slide 17: Backup Slides Second Quarter Figures 2022
Backup Slides Second Quarter Figures 2022
Slide 18: Second Quarter 2022 – Group Overview
18 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Group1 Overview Geographic split – Europe with strong sales growth driven by Care Chemicals (both Consumer Care and Industrial Applications) and notable expansion in Natural Resources (all Business Units), weaker Sales
Slide 19: Second Quarter 2022 – Sales and EBITDA by Business Area
19 Second Quarter / First Half Year Results 2022 28.07.2022 Second Quarter 2022 – Sales and EBITDA by Business Area Sales EBITDA 20212 in CHF m 2022 2021 % LC1 2022 % CHF (restated) Care Chemicals 551 384 + 46 % 133 76 + 75 % margin 24.1 % 19.8 % Catalysis 232 221 +8% 13 42 - 69 % margin 5.6 % 19.0
Slide 20: First Half Year 2022 – Group Overview
20 Second Quarter / First Half Year Results 2022 28.07.2022 First Half Year 2022 – Group1 Overview Geographic split – European sales growth supported by resounding expansion at Care Chemicals (Consumer Care and Industrial Applications) and Natural Resources (all Business Units) Sales CHF 2 563 m Eme
Slide 21: First Half Year 2022 – Sales and EBITDA by Business Area
21 Second Quarter / First Half Year Results 2022 28.07.2022 First Half Year 2022 – Sales and EBITDA by Business Area Sales to third parties EBITDA 20212 in CHF m 2022 2021 % LC1 2022 % CHF (restated) Care Chemicals 1 117 788 + 45 % 263 156 + 69 % margin 23.5 % 19.8 % Catalysis 417 414 +4% 27 80 - 66
Slide 22: First Half Year 2022 – Consolidated Statements of Cash Flows
22 Second Quarter / First Half Year Results 2022 28.07.2022 First Half Year 2022 – Consolidated Statements of Cash Flows All figures including discontinued operations H1 20211 in CHF m H1 2022 (restated) − First Half Year 2022 net result from continuing Net result from continuing operations 189 105
Slide 23: EBITDA / EBIT Bridge H1 2022
23 Second Quarter / First Half Year Results 2022 28.07.2022 EBITDA / EBIT Bridge H1 2022 Group continuing operations (CHF m) Care Chemicals (CHF m) EBITDA Exceptional Exceptional EBITDA Exceptional Exceptional bei items EBITDA D&I1 EBITA Amortization EBIT items EBIT bei bei items EBITDA D&I1 EBITA A
Slide 24: Debt Maturity Profile as of 30 June 2022
24 Second Quarter / First Half Year Results 2022 28.07.2022 Debt Maturity Profile as of 30 June 2022 Liquidity Financial Debt Maturities in CHF m in CHF m Cash and short-term deposits 617 CHF bond Certificate of indebtedness Short-term loans, lease & other liabilities Derivatives 348 313 283 287 175
Slide 25: Calendar of Upcoming Corporate Events
25 Second Quarter / First Half Year Results 2022 28.07.2022 Calendar of Upcoming Corporate Events 27 October 2022 Third Quarter / Nine Month 2022 Reporting 01 March 2023 Fourth Quarter / Full Year 2022 Reporting 04 April 2023 Annual General Meeting
Slide 26: IR Contacts
26 Second Quarter / First Half Year Results 2022 28.07.2022 IR Contacts Andreas Schwarzwälder Phone: +41 61 469 63 73 Head of Investor Relations Email: investor-relations@clariant.com Maria Ivek Senior Investor Relations Officer Alexander Kamb Investor Relations Officer